Ocular Hypertension News and Research

RSS
Ultra-processed foods linked to higher glaucoma risk, study warns

Ultra-processed foods linked to higher glaucoma risk, study warns

Can genome editing transform ocular disease treatment?

Can genome editing transform ocular disease treatment?

Intracranial pressure plays a key role in normal-tension glaucoma

Intracranial pressure plays a key role in normal-tension glaucoma

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

Mechanism behind how certain osmolytes cause kidney damage revealed

Mechanism behind how certain osmolytes cause kidney damage revealed

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

Smartphones could be used to reveal early-warning signs of glaucoma

Smartphones could be used to reveal early-warning signs of glaucoma

Novel mechanism that may confer protection against glaucoma identified

Novel mechanism that may confer protection against glaucoma identified

Tips on making a smooth transition to optimal eye care

Tips on making a smooth transition to optimal eye care

Trifocal lenses: the best chance of true spectacle independence?

Trifocal lenses: the best chance of true spectacle independence?

Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

New, regenerative medicine approach developed to remove congenital cataracts in infants

New, regenerative medicine approach developed to remove congenital cataracts in infants

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

Amakem commences Phase 2 dose-ranging study of AMA0076 drug for treatment of glaucoma

Glial cells promise as new target to modulate retinal synaptic plasticity after retinal injury

Glial cells promise as new target to modulate retinal synaptic plasticity after retinal injury

Aerie Pharmaceuticals announces dosing of first patients in PG324 Phase 2b study

Aerie Pharmaceuticals announces dosing of first patients in PG324 Phase 2b study

Clues of "silent thief of sight”: Glaucoma

Clues of "silent thief of sight”: Glaucoma

Prostaglandin analogues cause droopy eyelids, new study finds

Prostaglandin analogues cause droopy eyelids, new study finds

Fixed-dose combination of drugs effectively lowers IOP

Fixed-dose combination of drugs effectively lowers IOP

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.